Systemic inflammation, blood-brain barrier vulnerability and cognitive / non-cognitive symptoms in Alzheimer disease: Relevance to pathogenesis and therapy
The incidence of dementia is increasing at an alarming rate, and has become a major public health concern. Alzheimer disease (AD) is the most common form of dementia and is characterized by progressive cognitive impairment. In addition to classical neuropathological features such as amyloid plaques...
Main Authors: | Shuko eTakeda, Naoyuki eSato, Ryuichi eMorishita |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2014-07-01
|
Series: | Frontiers in Aging Neuroscience |
Subjects: | |
Online Access: | http://journal.frontiersin.org/Journal/10.3389/fnagi.2014.00171/full |
Similar Items
-
The Roles of Lipid and Glucose Metabolism in Modulation of β-Amyloid, Tau, and Neurodegeneration in the Pathogenesis of Alzheimer disease
by: Naoyuki eSato, et al.
Published: (2015-10-01) -
Roles of Vascular and Metabolic Components in Cognitive Dysfunction of Alzheimer disease: Short- and Long-term Modification by Non-genetic Risk Factors
by: Naoyuki eSato, et al.
Published: (2013-11-01) -
Brain alterations and clinical symptoms of dementia in diabetes: Abeta/tau-dependent and independent mechanisms
by: Naoyuki eSato, et al.
Published: (2014-09-01) -
Cognitive Decline Due to Excess Synaptic Zn2+ Signaling in the Hippocampus
by: Atsushi eTakeda
Published: (2014-02-01) -
Possible Modification of Alzheimer Disease by Statins in Midlife: Interactions with Genetic and Non-Genetic Risk Factors
by: Mitsuru eShinohara, et al.
Published: (2014-04-01)